Cushing’s syndrome is a disorder that occurs when your body makes too much of the hormone cortisol over a long period of time. Cortisol is sometimes called the “stress hormone” because it helps your body respond to stress.
The latest news from Corcept Therapeutics on their Phase 3 GRACE clinical trial clinical trial is excellent. The drug relacorilant significantly reduced high blood pressure and blood sugar levels in people with endogenous Cushing’s syndrome.
In this podcast, we discuss the latest data on the incidence of Cushing’s disease worldwide based on a recent Swedish study on the subject, and the importance of disease awareness in early diagnosis.
Daphne Adelman is a clinical nurse specialist at Northwestern University. In her job at Northwestern, she manages and coordinates studies for pharmaceutical and National Institutes for Health-sponsored studies. Daphne’s work focuses on pituitary conditions like
In today’s podcast, Dr. Blevins focuses on a discussion of disorders of ACTH or Adrenocorticotropic Hormone in two recent cases from his practice. Adrenocorticotropic hormone (ACTH) is a hormone produced in the anterior, or front,
In this informative podcast, Dr. Lewis Blevins explores the long-term issues affecting people with Cushing’s disease and syndrome. For more information on Cushing’s download this series of podcasts. Music by Patrick Muecke
Today’s podcast is on ACTH producing pituitary adenomas. Dr. Blevins discusses the different factors and theories that lead to the development of these tumors, challenges in diagnosis and treatment. The podcast also highlights a few very interesting cases.
This podcast focuses on the results of our latest Pituitary World News survey on Cyclical Cushing’s Syndrome. Dr. Blevins offers his views and a very interesting, highly educational discussion on this condition. Look for our
UPDATED JULY 11, 2023 – From Lewis S. Blevins Jr., M.D. – Medical Director of the California Center for Pituitary Disorders at UCSF and Pituitary World News co-founder. Cushing’s disease is caused by the secretion
A conversation with Dr. Scott Struthers, Founder, and CEO of Crinetics Pharmaceutical. These are exciting times in the world of endocrine drug discovery and development, particularly for Acromegaly and Cushing’s patients. In today’s podcast we
From University of Rochester Medical Center this fascinating, very educational program on the diagnosis of a Cushing’s case. Thank you, Ruth Owens, for posting this informational piece on the Acromegaly Community Support Group Facebook page.
Today’s podcast is the first in an upcoming series of podcasts dedicated to pituitary lesions, with particular attention to pituitary adenomas. Dr. Blevins covers a variety of subjects including symptoms and signs, classification and groups,
From the desk of Dr. Lewis Blevins – cofounder – This article –Diagnosis of recurrence in Cushing’s disease: American Association of Clinical Endocrinologists and American College of Endocrinology Disease State Clinical Review – summarizes recent
The European Society of Endocrinology recently published a pituitary update with several interesting presentations. Of particular note, for those of you interested in the genetics of acromegaly, is a presentation by Albert Beckers a Belgian